Jerlyn O'Donnell™ (designlady) — Experience Design · Accessibility Hire me now
Jerlyn O'Donnell, founder of Design Lady LLC, standing among tropical foliage in an editorial portrait
FDA Approved Aesthetic Solution · NDA 2026-DL

Breakthrough Treatment for Chronic
Sub-par Interfaces.

Jerlyn O'Donnell™ (designlady) is now indicated for the immediate improvement of User Experience and Brand Aesthetic in digital ecosystems suffering from Chronic Interface Dermatitis (CID).

Schedule a call

All designer images are AI-generated.

Side Effects

Obsessive kerning, extreme satisfaction with line-height, sudden desire for custom illustration, heightened expectations for every subsequent project.

Common Adverse Reactions

Rapid promotion within the organization. Extreme stakeholder satisfaction. Accidental virality on social platforms.

Rare Reactions

Uncontrollable urge to fix every font on the internet. Spontaneous applause during presentations. Development of a "refined palette."

Contraindications & Warnings

Do not use if allergic to high-quality design or prefer Comic Sans. Highly addictive; prolonged exposure may reduce tolerance for non-expert design partners.

$0
New business generated via accessible design proposals
0
Virtual congress visitors in one week, vs. 447 avg in-person
0
AI applications shipped in under 6 months
0
Years across BGB Group, IPG Health, WPP, Havas
Drug Facts

Active Ingredients & Mechanism of Action

Active Ingredients

What's Inside Each Dose

  • 100mg Figma Precision
  • 50mg AI Workflow Stability
  • 200mcg Typographic Focus
Dosage & Administration

Recommended Regimen

One design sprint every 2 weeks until symptoms of "Default Bootstrap" fully subside. For acute brand emergencies, a loading dose of one prototype delivered in under 48 hours. Not recommended for projects with zero stakeholder alignment.

Phase III Results 99.8%

Reduction in user friction. Statistically significant (P < 0.001) vs. Bootstrap Placebo.

01

Discovery

Molecular analysis of the brand landscape and DNA.

02

Ideation

Rapid synthesis of visual concepts, forming multiple pathways.

03

Execution

Crystallization of the chosen concept into a production-ready design system.

04

Iteration

Post-launch analysis and AI-assisted refinement.

Study DP-003 · Phase III Clinical Data

Clinical Use Cases

Client-Confidential
Sign in to view
Regulated Healthcare · 2020

Virtual Congress Experience

79,641 visitors in one week
Client-Confidential
Sign in to view
Regulated Healthcare · 2025

Interactive Visual Aid

Under 10 days, brief to working prototype
Client-Confidential
Sign in to view
Public Health · 2020–2022

National Vaccine Information Platform

43% traffic growth
Client-Confidential
Sign in to view
Consumer / CPG · 2019

Consumer Wellness Website Redesign

79% increase in average time on site
Client-Confidential
Sign in to view
Agency / Product · 2024

AI Application Suite

9 AI applications shipped in under 6 months
Kwéyòl Donmnik Extension
Design Lady LLC · Independent · 2026

Kwéyòl Donmnik Chrome + Firefox Extension

8,550 entries, shipped in under 3 hours
Recognition

Verified & Approved

IAAP Certified CPACC Adobe Community Expert WCAG 2.1 AA: 76% → 94% compliance 98% reduction in CSS bloat
Jerlyn O'Donnell

Who am I?

Experience Design Director and founder of Design Lady LLC, an NYC M/WBE-certified accessibility and experience design firm. 15+ years directing UX for high-stakes, regulated, expert-facing digital platforms across BGB Group, IPG Health, WPP, and Havas. IAAP CPACC certified, Adobe Community Expert, and co-author of The Hybrid Business Engineer in the Age of AI.